Wockhardt acquires U.S. firm Morton Grove

Wednesday, 24 October 2007, 07:00 Hrs
Printer Print Email Email
Mumbai: Pharmaceutical and biotechnology major Wockhardt Ltd today announced the acquisition of Morton Grove Pharmaceuticals Inc, a leading healthcare company in the U.S with sales revenue of $52 million (2 billion).

"Morton Grove is a strategic acquisition for Wockhardt. It provides an entry into the US generic market with a portfolio of 31 products, 13 of which occupy number one market position," said Habil Khorakiwala, chairman, Wockhardt.

"Wockhardt now has a strong position in the liquid medicine market in the US and the UK," he added.

The company said that one third of its revenue comes from the branded Lindane range of dermatological products, and this acquisition will boost Wockhardt's US revenue by providing a complete range of dosage, right from tablets, capsules, liquids to injections.
Source: IANS
SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..